作者: Michael T. Halpern , Melissa A. Romaire , Susan G. Haber , Florence K. Tangka , Susan A. Sabatino
DOI: 10.1002/CNCR.28704
关键词:
摘要: BACKGROUND Although state Medicaid programs cover cancer screening, beneficiaries are less likely to be screened for and more present with tumors of an advanced stage than those other insurance. The current study was performed determine whether eligibility reimbursement policies affect the receipt breast, cervical, colon screening among beneficiaries. METHODS Cross-sectional regression analyses 2007 data from 46 states District Columbia were examine associations between state-specific reimbursement/eligibility screening. sample included individuals aged 21 years 64 who enrolled in fee-for-service at least 4 months. Subsamples eligible each test were: Papanicolaou 2,136,511 patients, mammography 792,470 colonoscopy 769,729 fecal occult blood 753,868 patients. State-specific variables median reimbursement, income/financial asset requirements, physician copayments, frequency renewal. RESULTS Increases demonstrated mixed (positive negative) likelihood receiving tests beneficiaries. In contrast, increased reimbursements office visits found positively associated odds all examined, including (odds ratio [OR], 1.07; 95% confidence interval [95% CI], 1.06-1.08), (OR, 1.09; CI, 1.08-1.10), 1.02; 1.02-1.03), 1.02-1.03). Effects varied across examined. CONCLUSIONS Increased consistently being cancer, may important policy tool increasing this vulnerable population. Cancer 2014;120:3016–3024. © 2014 American Society.